Inhibition of return in the human 5HT2A agonist and NMDA antagonist model of psychosis.

Patients with schizophrenia exhibit disturbances of orienting of attention. However, findings have been inconsistent. Pharmacologic challenges with hallucinogens have been used as models for psychosis.